Longitudinal Registry Including Patients Treated With Heavy Particles

Condition(s) studied

Investigational drug(s) / intervention(s)

Heavy-ion therapy (hadrontherapy): Only data available from routine clinical practice at the National Center for Oncological Hadrontherapy (CNAO), based Pavia, will be collected. Intervention is not assigned.

Study summary

The purpose of this registry is to collect retrospective and prospective standardized data of patients treated with particle therapy, either with protons or carbon ions, at the National Center for Oncological Hadrontherapy (CNAO) based in Pavia.

By keeping track of the patients treated, it will allow the investigators to periodically analyze and evaluate data collected of daily clinical activity. This will help gathering more information on the results of particle therapy and will provide the basis for in depth evaluation of patients' outcome with respect to the delivered treatment.

Eligibility

Primary outcome measure(s)

• Real world data collection — 50 years
  To collect real world data of patients treated with radiotherapy, to support particle radiotherapy and to provide evidence of the role of radiation oncology within the multidisciplinary approach.

Trial sites (1)

More CNAO National Center of Oncological Hadrontherapy trials in Italy

Other trials for the same condition